Kairos Pharma, Ltd.
Symbol: KAPA (NYSE)
0.94
▲ (1.08%) 0.010
Company Description:
Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. It is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.
Key Stats
- Today's Open: $0.9605
- Today's High: $1.005
- Today's Low: $0.903
- Today's Volume: 495.84K
- Yesterday Close: $0.93
- Yesterday High: $1.01
- Yesterday Low: $0.93
- Yesterday Volume: 895.80K
- Last Min Volume: 0
- Last Min High: $0.94
- Last Min Low: $0.909
- Last Min VWAP: $0
Company Profile
- Name: Kairos Pharma, Ltd.
- Website: https://www.kairospharma.com
- Listed Date: 2024-09-16
- Location: LOS ANGELES, CA
- Market Status: Active
- CIK Number: 0001962011
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $15.67M
- Round Lot: 100
- Outstanding Shares: 16.85M
- Asset Type: CS
RECENT FILINGS FOR KAPA
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-07-15 | 8-K | View |
| 2025-06-12 | 8-K | View |
| 2025-06-03 | 8-K | View |
| 2025-05-16 | DEFR14A | View |
| 2025-05-15 | SCHEDULE 13G | View |
| 2025-05-14 | 10-Q | View |
| 2025-05-06 | PRER14A | View |
| 2025-05-01 | DEF 14A | View |
| 2025-04-30 | 3 | View |
| 2025-04-29 | 10-K/A | View |
| 2025-04-28 | 8-K | View |
| 2025-04-25 | 424B3 | View |
| 2025-04-24 | EFFECT | View |
| 2025-04-24 | 8-K | View |
| 2025-04-22 | CORRESP | View |
| 2025-04-22 | S-1 | View |
| 2025-04-15 | 10-K | View |
| 2025-04-07 | 4 | View |
| 2025-03-28 | NT 10-K | View |
| 2025-03-20 | 8-K | View |
Latest News on KAPA